Success Metrics

Clinical Success Rate
71.4%

Based on 5 completed trials

Completion Rate
71%(5/7)
Active Trials
1(10%)
Results Posted
40%(2 trials)
Terminated
2(20%)

Phase Distribution

Ph phase_3
1
10%
Ph not_applicable
7
70%
Ph phase_2
1
10%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
1(11.1%)
N/ANon-phased studies
7(77.8%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(5)
Terminated(2)
Other(2)

Detailed Status

Completed5
unknown2
Terminated2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
71.4%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (11.1%)
Phase 31 (11.1%)
N/A7 (77.8%)

Trials by Status

recruiting110%
unknown220%
terminated220%
completed550%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
PROCEDURE
Total Trials
10